教員情報 - 小林　国彦 | 埼玉医科大学

教員情報トップぺージ

ホームページ

研究課題・受託研究・科研費

受賞履歴

著書

学術雑誌

学会発表

（最終更新日：2024-07-29 18:28:57）

  コバヤシ　クニヒコ   KOBAYASHI Kunihiko
  小林　国彦
   所属   埼玉医科大学医学部リサーチアドミニストレーションセンター

職種教授

■ ホームページ

http://homepage3.nifty.com/care-notebook/

■ 研究課題・受託研究・科研費

1.	2003/02～2006/12	イリノテカン不応の既治療小細胞肺癌に対するパクリタキセル + ニムスチン(ACNU)併用第Ⅱ相試験国内共同研究（キーワード：小細胞肺癌）
2.	2004/08～2005/09	EGFR遺伝子変異陽性非小細胞肺癌に対するGefitinib治療第２相試験機関内共同研究（キーワード：EGFR遺伝子、非小細胞肺癌、Gefitinib）
3.	2005/08～2007/07	抗癌剤投薬の適応のない、EGFR遺伝子変異陽性非小細胞肺癌に対する初回Gefitinib救済治療国内共同研究（キーワード：EGFR遺伝子、非小細胞肺癌、Gefitinib）
4.	2006/04～2009/03	EGFR遺伝子変異を有する未治療進行非小細胞肺癌に対するゲフィチニブとプラチナ併用化学療法との無作為化比較試験国内共同研究（キーワード：ゲフィチニブ、EGFR遺伝子変異、非小細胞肺癌）

■ 受賞履歴

1.	2011/04	文部科学大臣　科学技術賞
2.	2012/12	International Research Promotion Council (IRPC) World Scientists Forum International Award - Eminent Scientist of the Year 2012.

■ 著書

単行本　

「肺癌治療とＱＯＬ―臨床試験に焦点を当てて、Annual Review 2006 呼吸器」 2006/01

■ 学術雑誌

1.	学術雑誌(原著)	Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. 2010/06
2.	学術雑誌(原著)	First-line gefitinib for patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations without indication for chemotherapy. 2009/03
3.	学術雑誌(原著)	Phase I/II trial of a biweekly combination of S-1 plus docetaxel in patients with previously treated non-small cell lung cancer (KRSG-0601). Br J Cancer. 2012 Oct 23;107(9):1474-80 2012/10
4.	学術雑誌(原著)	Content Validity and Feasibility of the Care Notebook to Assess Cancer-Related Quality of Life in Hawaii 2012/12
5.	学術雑誌(総説)	Epidermal growth factor receptor (EGFR) mutation and personalized therapy in advanced nonsmall cell lung cancer (NSCLC) 2013/05
6.	学術雑誌(原著)	Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin-paclitaxel for chemo-naive non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002) 2013/01
7.	学術雑誌(原著)	Quality of Life with Gefitinib in Patients with EGFR-Mutated Non-Small Cell Lung Cancer: Quality of Life Analysis of North East Japan Study Group 002 Trial. 2012/06
8.	学術雑誌(総説)	Importance of the cytological samples for the epidermal growth factor receptor gene mutation test for non-small cell lung cancer. Cancer Sci. 2013/05
9.	学術雑誌(原著)	A Phase II Trial of Afatinib in Patients With Advanced Non-Small-Cell Lung Cancer Who Progressed During Prior Treatment With Erlotinib, Gefitinib, or Both. 2013/09
10.	学術雑誌(原著)	Dissociative stupor mimicking consciousness disorder in an advanced lung cancer patient. 2012/06
11.	学術雑誌(原著)	Biweekly administration of irinoteca (CPT-!!) plus cisplatin with an antidiarreal program of intestinal alkalization to reduce diarrhea in cancer patients, 2012/12
12.	学術雑誌(原著)	Successful treatment of carcinomatous meningitis with erlotinib and whole brain radiotherapy, 2012/12
13.	学術雑誌(原著)	First-line gefitinib in patients aged 75 or older with advanced non-small cell lung cancer harboring epidermal growth factor receptor mutations: NEJ 003 study. 2012/09
14.	学術雑誌(原著)	Low-dose gefitinib treatment for patients with advanced non-small cell lung cancer harboring sensitive epidermal growth factor receptor mutations. 2011/08
15.	学術雑誌(原著)	LUX-Lung 4: A Phase II Trial of Afatinib in Patients With Advanced Non-Small-Cell Lung Cancer Who Progressed During Prior Treatment With Erlotinib, Gefitinib, or Both. 2013/09
16.	学術雑誌(原著)	Pharmacokinetics of a new fentanyl tape with a novel delivery system of transdermal matrix patches in patients with cancer pain. 2014/01
17.	学術雑誌(原著)	Interstitial lung disease associated with gefitinib in Japanese patients with EGFR-mutated non-small-cell lung cancer: combined analysis of two Phase III trials (NEJ 002 and WJTOG 3405). 2013/06
18.	学術雑誌(原著)	The peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based test for epidermal growth factor receptor mutations in bronchoscopic cytological specimens of non-small cell lung cancer. 2012/06
19.	学術雑誌(原著)	Gefitinib for non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) gene mutations screened by Peptide Nucleic Acid-Locked Nucleic Acid PCR clamp 2006/12
20.	学術雑誌(原著)	Combination Chemotherapy of Alternating Etoposide and Carboplatin with Weekly Administration of Irinotecan and Cisplatin in Extensive-stage Small-cell Lung Cancer 2012/10
21.	学術雑誌(原著)	Prediction of the pathogens that are the cause of pneumonia by the battlefield hypothesis. 2011/09
22.	学術雑誌(原著)	Illness perceptions and quality of life in Japanese and Dutch patients with non-small-cell lung cancer. 2011/06
23.	学術雑誌(原著)	Combined survival analysis of prospective clinical trials of gefitinib for non-small cell lung cancer with EGFR mutations. 2009/07
24.	学術雑誌(原著)	Frequency of and variables associated with the EGFR mutation and its subtypes. 2010/03
25.	学術雑誌(原著)	Alternating chemotherapy with amrubicin plus cisplatin and weekly administration of irinotecan plus cisplatin for extensive-stage small cell lung cancer. 2013/03
26.	学術雑誌(原著)	A. Phase II study of nimustine hydrochloride (ACNU) plus paclitaxel for refractory small cell lung cancer. 2009/03
27.	学術雑誌(原著)	Effects of socioeconomic factors and cancer survivors' worries on their quality of life (QOL) in Japan. 2008/06
28.	学術雑誌(原著)	Peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based detection test for gefitinib-refractory T790M epidermal growth factor receptor mutation. 2008/03
29.	学術雑誌(原著)	Reliability of the peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based test for epidermal growth factor receptor mutations integrated into the clinical practice for non-small cell lung cancers. 2007/07
30.	学術雑誌(原著)	Cross-cultural validation of the Japanese version of the lung cancer subscale on the functional assessment of cancer therapy-lung. 2007/12
31.	学術雑誌(原著)	E-cadherin Expression Can Predict Survival of Non-Small Cell Lung Cancer Patients Treated with an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor. 2008/02
32.	学術雑誌(原著)	Mutations in the SLC34A2 Gene are Associated with the Pulmonary Alveolar Microlithiasis. 2006/02
33.	学術雑誌(原著)	A phase I/II trial of irinotecan-cisplatin combined with an anti-late-diarrhoeal　programme to evaluate the safety and antitumour response of this combination　therapy in patients with advanced non-small-cell lung cancer. 2005/12
34.	学術雑誌(原著)	Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp. 2005/08
35.	学術雑誌(原著)	Validation of the Care Notebook for measuring physical, mental and “life well-being” of patients with cancer 2005/05
36.	学術雑誌(原著)	HIRA-TAN: a real-time PCR-based system for the rapid identification of causative agents in pneumonia. 2014/02
37.	学術雑誌(原著)	Validation study of a desease-specific module, the Athma Health Questionnaire (AHQ) using Japanese adult asthmatic patients 2005/03
38.	学術雑誌(原著)	Cross-cultural validation of the Japanese　Functional Assessment of Cancer Therapy-Anemia (FACT-An). 2004/10
39.	学術雑誌(原著)	Weekly administration of irinotecan (CPT-11) plus cisplatin for refractory or relapsed small cell lung cance 2004/04
40.	学術雑誌(原著)	Immunotherapy or Chemoimmunotherapy in Older Adults With Advanced Non-Small Cell Lung Cancer. 2024/04/01
41.	学術雑誌(原著)	CNS Efficacy of Osimertinib With or Without Chemotherapy in Epidermal Growth Factor Receptor- Mutated Advanced Non-Small-Cell Lung Cancer. 2024/03/01
42.	学術雑誌(原著)	Immunotherapy With Radiotherapy for Brain Metastases in Patients With NSCLC: NEJ060. 2024/02/20
43.	学術雑誌(原著)	Risk Factors for Bleeding Events in Japanese Patients with Advanced Lung Cancer: 2024/01/10
44.	学術雑誌(原著)	A phase II study of atezolizumab with bevacizumab, carboplatin, and paclitaxel for patients with EGFR-mutated NSCLC after TKI treatment failure (NEJ043 study). 2024/01
45.	学術雑誌(原著)	Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC. 2023/11/08
46.	学術雑誌(原著)	Clinicopathological impact of VEGFR2 and VEGF-C in patients with EGFR-major mutant NSCLC receiving osimertinib. 2023/11/01
47.	学術雑誌(原著)	Detection of multiple druggable mutations of lung cancer from cytology specimens by MINtS: An advanced medicine A trial. 2023/08
48.	学術雑誌(原著)	A Phase I/II Study of Necitumumab Plus Pembrolizumab, Nab-Paclitaxel, and Carboplatin for Previously Untreated Advanced Squamous Non-Small Cell Lung Cancer Study: (NEJ048A/NEXUS). 2023/06
49.	学術雑誌(原著)	Detection of multiple druggable mutations of lung cancer from cytology specimens by MINtS: An advanced medicine A trial. 2023/05/03
50.	学術雑誌(原著)	Phase 2 study of osimertinib in combination with platinum and pemetrexed in patients with previously untreated EGFR-mutated advanced non-squamous non-small cell lung cancer: The OPAL Study. 2023/05
51.	学術雑誌(原著)	A randomized controlled phase III trial protocol: perioperative pirfenidone therapy in patients with non-small cell lung cancer combined with idiopathic pulmonary fibrosis to confirm the preventative effect against postoperative acute exacerbation: the PIII-PEOPLE study (NEJ034). 2023/03/31
52.	学術雑誌(原著)	Phase 2 study of osimertinib in combination with platinum and pemetrexed in patients with previously untreated EGFR-mutated advanced non-squamous non-small cell lung cance 2023/03/02
53.	学術雑誌(原著)	Identification of risk factors for venous thromboembolism and validation of the Khorana score in patients with advanced lung cancer: based on the multicenter, prospective Rising-VTE/NEJ037 study data. 2023/01/28
54.	学術雑誌(原著)	A Phase I/II Study of Necitumumab Plus Pembrolizumab, Nab-Paclitaxel, and Carboplatin for Previously Untreated Advanced Squamous Non-Small Cell Lung Cancer Study: (NEJ048A/NEXUS). 2023/01/24
55.	学術雑誌(原著)	Prognostic significance of tumor infiltrating lymphocytes on first-line pembrolizumab efficacy in advanced non-small cell lung cancer. 2023/01/20
56.	学術雑誌(原著)	Design and rationale of the Japanese Idiopathic Interstitial Pneumonias (JIPS) Registry 2023/01
57.	学術雑誌(原著)	A phase II study of carboplatin and etoposide plus durvalumab for previously untreated extensive-stage small-cell lung cancer (ES-SCLC) patients with a poor performance status (PS): NEJ045A study protocol. 2022/11/04
58.	学術雑誌(原著)	Updated Analysis of NEJ009: Gefitinib-Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated EGFR. 2022/11/01
59.	学術雑誌(原著)	Prognostic Potential of Metabolic Activity on 18F-FDG Accumulation in Advanced NSCLC Receiving Combining Chemotherapy Plus PD-1 Blockade. 2022/10/19
60.	学術雑誌(症例報告)	Metachronous lesions in the orbit, retroperitoneum, and pleura of mucosa-associated lymphoid tissue lymphoma: A case report. 2022/10
61.	学術雑誌(原著)	Real-world outcomes of chemotherapy for lung cancer patients undergoing hemodialysis: A multicenter retrospective cohort study (NEJ-042) 2022/10
62.	学術雑誌(原著)	Incidence of venous thromboembolism in advanced lung cancer and efficacy and safety of direct oral anticoagulants: a multicenter, prospective, observational study (Rising-VTE/NEJ037 study). 2022/07/21
63.	学術雑誌(原著)	Pretreatment body mass index predicts survival among patients administered nivolumab monotherapy for pretreated non-small cell lung cancer. 2022/05
64.	学術雑誌(原著)	Phase II study of carboplatin-paclitaxel alone or with bevacizumab in advanced sarcomatoid carcinoma of the lung: HOT1201/NEJ024. 2022/04/27
65.	学術雑誌(原著)	A new risk-assessment tool for venous thromboembolism in advanced lung cancer: a prospective, observational study. 2022/04/04
66.	学術雑誌(原著)	A randomized controlled phase III trial protocol: perioperative pirfenidone therapy in patients with non-small cell lung cancer combined with idiopathic pulmonary fibrosis to confirm the preventative effect against postoperative acute exacerbation: the PIII-PEOPLE study (NEJ034). 2022/03/31
67.	学術雑誌(原著)	Effects of a Self-Monitoring Quality of Life Intervention in Outpatients with Breast Cancer: A Preliminary Report of A Randomized Controlled Trial. 2022/01/01
68.	学術雑誌(原著)	Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy. 2021/08
69.	学術雑誌(原著)	Perceptions of Japanese and Dutch women with early breast cancer about monitoring their quality of life. 2021/07
70.	学術雑誌(その他)	A Phase II Study of Osimertinib Combined With Platinum Plus Pemetrexed in Patients With EGFR-Mutated Advanced Non-Small-cell Lung Cancer: The OPAL Study (NEJ032C/LOGIK1801). 2021/05/22
71.	学術雑誌(原著)	Efficacy and Feasibility of Programmed Death-1/Programmed Death Ligand-1 Blockade Therapy in Non-Small Cell Lung Cancer Patients With High Antinuclear Antibody Titers. 2021/05/15
72.	学術雑誌(原著)	A phase II study of first-line afatinib for patients aged ≥75 years with EGFR mutation-positive advanced non-small cell lung cancer: North East Japan Study Group trial NEJ027. 2021/05/01
73.	学術雑誌(原著)	Osimertinib versus osimertinib plus chemotherapy for non-small cell lung cancer with EGFR (T790M)-associated resistance to initial EGFR inhibitor treatment: An open-label, randomised phase 2 clinical trial. 2021/05/01
74.	学術雑誌(原著)	Effectiveness of EGFR-TKI rechallenge immediately after PD-1 blockade failure. 2021/05
75.	学術雑誌(原著)	Clinical impact of post-progression survival on overall survival in patients receiving nivolumab monotherapy as a second-line treatment for advanced non-small cell lung cancer. 2021/04/12
76.	学術雑誌(原著)	Efficacy and Feasibility of Programmed Death-1/Programmed Death Ligand-1 Blockade Therapy in Non-Small Cell Lung Cancer Patients With High Antinuclear Antibody Titers. 2021/03/15
77.	学術雑誌(原著)	Pre-existing interstitial lung disease does not affect prognosis in non-small cell lung cancer patients with PD-L1 expression ≥50% on first-line pembrolizumab. 2021/02/12
78.	学術雑誌(その他)	Protocol for a multi-site, cluster-randomized, phase III, comparative clinical trial of geriatric assessment of older patients with non-small-cell lung cancer: the ENSURE-GA study. 2021/01/22
79.	学術雑誌(症例報告)	Primary thymic adenocarcinoma with an aggressive clinical course: An autopsy case showing signet ring cell‐like features 2020/12
80.	学術雑誌(その他)	A phase II study of daily carboplatin plus irradiation followed by durvalumab for stage III non-small cell lung cancer patients with PS 2 up to 74 years old and patients with PS 0 or 1 from 75 years: NEJ039A (trial in progress). 2020/10/06
81.	学術雑誌(原著)	Prognostic factors for patients with metastatic or recurrent thymic carcinoma receiving palliative-intent chemotherapy. 2020/10
82.	学術雑誌(症例報告)	Recovery of the Sensitivity to Anti-PD-1 Antibody by Celecoxib in Lung Cancer. 2020/09/04
83.	学術雑誌(原著)	Bevacizumab plus chemotherapy in nonsquamous non-small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: A phase II study North East Japan Study group trial NEJ013B. 2020/07
84.	学術雑誌(原著)	Chemoradiotherapy followed by durvalumab in patients with unresectable advanced non-small cell lung cancer: Management of adverse events 2020/05/01
85.	学術雑誌(原著)	Clinical Outcomes of Second-Line Chemotherapy in Patients with Previously Treated Advanced Thymic Carcinoma: A Retrospective Analysis of 191 Patients from the NEJ023 Study. 2020/04/25
86.	学術雑誌(原著)	Potential of FDG-PET as Prognostic Significance after anti-PD-1 Antibody against Patients with Previously Treated Non-Small Cell Lung Cancer 2020/03/07
87.	学術雑誌(総説)	Illness Perceptions and Quality of Life in Patients with Non-Small-Cell Lung Cancer: A 3-Month Follow-Up Pilot Study. 2020/02/27
88.	学術雑誌(原著)	Gefitinib Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated Epidermal Growth Factor Receptor: NEJ009 Study. 2020/01/10
89.	学術雑誌(原著)	Clinical difference between discontinuation and retreatment with nivolumab after immune-related adverse events in patients with lung cancer 2019/10
90.	学術雑誌(原著)	Re-challenge of afatinib after 1st generation EGFR-TKI failure in patients with previously treated non-small cell lung cancer harboring EGFR mutation 2019/05
91.	学術雑誌(原著)	Clinical significance of primary prophylactic pegylated-granulocyte-colony stimulating factor after the administration of ramucirumab plus docetaxel in patients with previously treated non-small cell lung cancer 2019/04
92.	学術雑誌(原著)	Different incidence of interstitial lung disease according to different kinds of EGFR-tyrosine kinase inhibitors administered immediately before and/or after anti-PD-1 antibodies in lung cancer 2019/04
93.	学術雑誌(原著)	Improved efficacy of ramucirumab plus docetaxel after nivolumab failure in previously treated non-small cell lung cancer patients 2019/04
94.	学術雑誌(原著)	Distinctive clinicopathological features of adenocarcinoma in situ and minimally invasive adenocarcinoma of the lung: A retrospective study. 2019/03
95.	学術雑誌(症例報告)	Spontaneous aspiration of a long tree twig as foreign body 2019/02
96.	学術雑誌(症例報告)	Spontaneous aspiration of a long tree twig as foreign body. 2019/02
97.	学術雑誌(原著)	Effects of a Self-Monitoring Quality of Life Intervention for Patients with Cancer Receiving Palliative Care in Japan: Study Protocol for a Randomized Controlled Trial. 2018/11
98.	学術雑誌(総説)	Prognostic Factors and Efficacy of First-Line Chemotherapy in Patients with Advanced Thymic Carcinoma: A Retrospective Analysis of 286 Patients from NEJ023 Study. 2018/10
99.	学術雑誌(症例報告)	Wernicke encephalopathy in a lung cancer patient during treatment with nivolumab. 2018/08/03
100.	学術雑誌(原著)	Phase I Study Evaluating the Combination of Afatinib with Carboplatin and Pemetrexed After First-line EGFR-TKIs. 2018/08
101.	学術雑誌(原著)	Prognostic Factors and Efficacy of First-Line Chemotherapy in Patients with Advanced Thymic Carcinoma: A Retrospective Analysis of 286 Patients from NEJ023 Study. 2018/03
102.	学術雑誌(原著)	Updated survival outcomes of NEJ005/TCOG0902: a randomised phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations. 2018/02
103.	学術雑誌(原著)	Cross-cultural comparison of breast cancer patients' Quality of Life in the Netherlands and Japan. 2017/11
104.	学術雑誌(原著)	The international phase 4 validation study of the EORTC QLQ-SWB32, A standalone measure of spiritual well-being for people receiving palliative care for cancer 2017/11
105.	学術雑誌(原著)	A highly specific and sensitive massive parallel sequencer-based test for somatic mutations in non-small cell lung cancer 2017/04
106.	学術雑誌(原著)	A phase II study of carboplatin plus weekly paclitaxel with bevacizumab for elderly patients with non-squamous non-small-cell lung cancer (NEJ016) 2017/04
107.	学術雑誌(原著)	Pharmacokinetic evaluation of intrapleural perfusion with hyperthermic chemotherapy using cisplatin in patients with malignant pleural effusion 2017/01
108.	学術雑誌(原著)	Identification of adverse events that have a negative impact on quality of life in a clinical trial comparing docetaxel versus S-1 with cisplatin in lung cancer 2016/10
109.	学術雑誌(原著)	A phase II study of bevacizumab with carboplatin-pemetrexed in non-squamous non-small cell lung carcinoma patients with malignant pleural effusions: North East Japan Study Group Trial NEJ013A 2016/09
110.	学術雑誌(原著)	Treatments and outcomes of advanced/recurrent non-small cell lung cancer harboring the EGFR T790M mutation: A retrospective observational study of 141 patients in Japan 2016/09
111.	学術雑誌(原著)	The effects of illness beliefs and chemotherapy impact on quality of life in Japanese and Dutch patients with breast or lung cancer 2016/05
112.	学術雑誌(原著)	CT features of epidermal growth factor receptor-mutated adenocarcinoma of the lung: Comparison with nonmutated adenocarcinoma 2016/02
113.	学術雑誌(その他)	Comparison of Gefitinib Versus Chemotherapy in Patients with Non-small Cell Lung Cancer with Exon 19 Deletion. 2015/12
114.	学術雑誌(総説)	We're in this together: Patients', caregivers' and health care providers' illness perceptions about non-small-cell lung cancer (NSCLC). 2015/12
115.	学術雑誌(原著)	Carcinomatous meningitis and EGFR mutation 2015/11
116.	学術雑誌(その他)	Current status and future perspectives of cooperative study groups for lung cancer in Japan. 2015/11
117.	学術雑誌(原著)	A randomized phase III trial of oral S-1 plus cisplatin versus docetaxel plus cisplatin in Japanese patients with advanced non-small-cell lung cancer: TCOG0701 CATS trial. 2015/07
118.	学術雑誌(原著)	Efficacy of chemotherapy after first-line gefitinib therapy in EGFR mutation-positive advanced non-small cell lung cancer-data from a randomized Phase III study comparing gefitinib with carboplatin plus paclitaxel (NEJ002). 2015/07
119.	学術雑誌(原著)	Factors associated with a poor response to gefitinib in the NEJ002 study: smoking and the L858R mutation. 2015/05
120.	学術雑誌(その他)	Hange-Shashin-to for preventing diarrhea during afatinib therapy 2015/05
121.	学術雑誌(原著)	Randomized phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations: NEJ005/TCOG0902 2015/05
122.	学術雑誌(原著)	Phase II Study of Amrubicin Combined with Carboplatin for Thymic Carcinoma and Invasive Thymoma: North Japan Lung Cancer Group Study 0803. 2014/12
123.	学術雑誌(症例報告)	The long-term outcomes of induction chemoradiotherapy followed by surgery for locally advanced non-small cell lung cancer 2014/10
124.	学術雑誌(原著)	Efficacy of chemotherapy after first-line gefitinib therapy in EGFR mutation-positive advanced non-small cell lung cancer-data from a randomized Phase III study comparing gefitinib with carboplatin plus paclitaxel (NEJ002). 2014/07
125.	学術雑誌(原著)	Current status and future perspectives of cooperative study groups for lung cancer in Japan. 2014/06
126.	学術雑誌(原著)	Factors associated with a poor response to gefitinib in the NEJ002 study: smoking and the L858R mutation. 2014/05
127.	学術雑誌(原著)	Randomized phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations: NEJ005/TCOG0902. 2014/05
128.	学術雑誌(原著)	Lung cancer patients frequently visit the emergency room for both cancer-related and unrelated issues. 2014/03
129.	学術雑誌(原著)	A phase II study of erlotinib monotherapy in pre-treated non-small cell lung cancer without EGFR gene mutation who have never/light smoking history: Re-evaluation of EGFR gene status (NEJ006/TCOG0903). 2014/02
130.	学術雑誌(原著)	Effectiveness of gefitinib against non-small-cell lung cancer with the uncommon EGFR mutations G719X and L861Q. 2014/02
131.	学術雑誌(原著)	Cross-cultural development of the EORTC QLQ-SWB36: A stand-alone measure of spiritual wellbeing for palliative care patients with cancer. 2013/05
132.	学術雑誌(原著)	Hemithoracic Intensity-modulated Radiotherapy Using Helical Tomotherapy for Patients after Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma 2012/02/25
133.	学術雑誌(原著)	Weekly administration of irinotecan (CPT-11) plus cisplatin for non-small cell lung cancer 2006/12
134.	学術雑誌(原著)	Analysis of incomplete quality of life data in advanced stage cancer: a practical application of multiple imputation. 2005/06
135.	学術雑誌(原著)	Weekly assessment of quality of life in patients with advanced non-small-cell lung cancer during chemotherapy in a randomized phase III trial. 2004/12
5件表示
全件表示(135件)

■ 学会発表

1.	ワークショップ７ Intergroup Study ― NEJ の立場から（口頭発表，一般） 2013/08/30